Inhibition of DOT1L and PRMT5 promote synergistic anti-tumor activity in a human MLL leukemia model induced by CRISPR/Cas9

Secker, Kathy-Ann; Keppeler, Hildegard; Duerr-Stoerzer, Silke; Schmid, Hannes; Schneidawind, Dominik; Hentrich, Thomas; Schulze-Hentrich, Julia M.; Mankel, Barbara; Fend, Falko; Schneidawind, Corina

dc.contributor.author	Secker, Kathy-Ann
dc.contributor.author	Keppeler, Hildegard
dc.contributor.author	Schmid, Hannes
dc.contributor.author	Schneidawind, Dominik
dc.contributor.author	Hentrich, Thomas
dc.contributor.author	Mankel, Barbara
dc.contributor.author	Fend, Falko
dc.contributor.author	Schneidawind, Corina
dc.contributor.author	Dürr-Störzer, Silke
dc.contributor.author	Schulze-Hentrich, Julia Maria
dc.date.accessioned	2020-08-10T10:12:05Z
dc.date.available	2020-08-10T10:12:05Z
dc.date.issued	2019
dc.identifier.issn	1476-5594
dc.identifier.uri	http://hdl.handle.net/10900/104577
dc.language.iso	en	de_DE
dc.publisher	Nature Publishing Group	de_DE
dc.relation.uri	http://dx.doi.org/10.1038/s41388-019-0937-9	de_DE
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	Inhibition of DOT1L and PRMT5 promote synergistic anti-tumor activity in a human MLL leukemia model induced by CRISPR/Cas9	de_DE
dc.type	Article	de_DE
utue.quellen.id	20200409032300_00473
utue.publikation.seiten	7181-7195	de_DE
utue.personen.roh	Secker, Kathy-Ann
utue.personen.roh	Keppeler, Hildegard
utue.personen.roh	Duerr-Stoerzer, Silke
utue.personen.roh	Schmid, Hannes
utue.personen.roh	Schneidawind, Dominik
utue.personen.roh	Hentrich, Thomas
utue.personen.roh	Schulze-Hentrich, Julia M.
utue.personen.roh	Mankel, Barbara
utue.personen.roh	Fend, Falko
utue.personen.roh	Schneidawind, Corina
dcterms.isPartOf.ZSTitelID	Oncogene	de_DE
dcterms.isPartOf.ZS-Issue	46	de_DE
dcterms.isPartOf.ZS-Volume	38	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE